GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hypera HYPE3.SA · BRL

Health Care · B3 · 🇧🇷 Brazil

Compare

22.48

+1.67%

Close of 9 Nov 2026, in BRL

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Hypera

Its shares trade on B3 under the ticker HYPE3.SA. It has been listed since 16 April 2008. In the fiscal year to 31 December 2025, it reported revenue of BRL 7.70bn and net income of BRL 1.20bn. At that date it held total assets of BRL 25.16bn and shareholders' equity of BRL 12.52bn.

Hypera SA is a pharmaceutical company, which engages in the manufacture and distribution of medical and cosmetics products. The company is headquartered in Sao Paulo, Sao Paulo. The company went IPO on 2008-04-16. The Company’s major business units include Branded Prescription, Consumer Health and Branded Generics. Branded Prescription is present in the main therapeutic classes in Brazil and it operates in the Primary Care segment under the umbrella brand Mantecorp Farmasa. The Branded Prescription unit also acts as Mantecorp Skincare in dermocosmetics, with products recommended by dermatologists. Consumer Health offers non-prescription drugs, with brands such as Apracur, Benegrip, Coristina d, Engov, Epocler and Estomazil, among others. The Consumer Health unit also operates in nutritionals and vitamin supplements, with brands such as Tamarine, Vitasay, Biotonico Fontoura and Zero-Cal. Branded Generics operates under the Neo Quimica brand.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
16 Apr 2008
Employees
8,918

Leadership

Pay as last reported

  • Mr. Alvado Stainfeld LinkChairman of the Board
  • Mr. Breno Toledo De OliveiraChief Executive Officer, since 2011
  • Mr. Ramon Sanches Frutuoso SilvaChief Financial Officer
  • Ms. Juliana Aguinaga Damiao SalemExecutive Officer - Legal Department
  • Mr. Rafael Vito BatistaExecutive Officer
  • Mr. Adalmario Do CoutoInvestor Relations Officer, Business Development Officer
  • Ms. Luciana Cavalheiro De QueirozMember of the Board of Directors
  • Mr. Esteban Malpica FomperosaMember of the Board of Directors
  • Mr. Bernardo Malpica HernandezMember of the Board of Directors
  • Mr. Hugo Barreto Sodre LealMember of the Board of Directors
  • Mr. Mauro Gentile Rodrigues Da CunhaIndependent Member of the Board of Directors
  • Ms. Eliana Helena De Gregorio AmbrosioIndependent Member of the Board of Directors

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
87
Environment
91
Social
99
Governance
71
Direct emissions (scope 1)
23,706.63 t
Energy emissions (scope 2)
5,997.19 t
Value chain emissions (scope 3)
20,464.94 t
Women in the workforce
52.65%
Carbon reduction policy
Yes
Human rights policy
Yes

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.